Pall Corporation out of Port Washington, NY has released a new blood filtration system that can screen out leukocytes, as well as prions. The Leukotrap Affinity Plus System already obtained European approval and is meant to be used as a filter for donated blood, that might be contaminated by prions. Prions, of course, are responsible for spongiform encephalopathy, and are difficult to detect since carriers often are not aware of their condition until symptoms arrive.
From the product page:
The filter system captures and reduces target contaminants while allowing the desired components to pass through, even those of equal or larger size.
Efficacy – Averaging greater than 3 log prion reduction Efficiency – Leucocyte reduction meeting current EU and UK guidelines Assurancen – Maintains therapeutic benefit of red cells Easy to Use – Self priming filter for ease of use Fast – Rapid filtration High Yield – With unique recovery system
Press release: Pall Corporation Launches Next Generation Blood Filter that Simultaneously Reduces Prions and Leukocytes …
Product page: Leukotrap Affinity Plus …